[SYRS] QoQ Quarter Result on 31-Dec-2016 [#Q4]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
20-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- 22.61%
YoY- -2.58%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Revenue 0 0 1,101 317 0 0 0 -
PBT -13,825 -13,368 -11,515 -10,965 -14,169 -12,021 -10,588 19.44%
Tax 0 0 0 0 0 0 0 -
NP -13,825 -13,368 -11,515 -10,965 -14,169 -12,021 -10,588 19.44%
Tax Rate - - - - - - - -
Total Cost 13,825 13,368 12,616 11,282 14,169 12,021 10,588 19.44%
Ratio Analysis
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
NP Margin 0.00 0.00 -1,045.87 -3,458.99 0.00 0.00 0.00 -
Per Share
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
EPS -5.26 -5.23 -4.92 -4.69 -6.44 -47.08 -4.65 8.55%
EPS Diluted -5.26 -5.23 -4.92 -4.69 -6.44 -47.08 -4.65 8.55%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.